Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
Authors
Posts by lungcanc
lungcanc
526 POSTS
0 COMMENTS
Disrupting the Paradigm: Partnering With Oncogene-Focused Patient Groups to Propel Research
lungcanc
Member Story: Dr. Shengxiang Ren
lungcanc
Member Story: Dr. Amy Moore
lungcanc
Member Stories: Dr. Ross Soo
lungcanc
Member Stories: Dr. Brendon Stiles
lungcanc
Member Stories: Dr. Anand Sachithanandan
lungcanc
Member Stories: Dr. Narjust Duma
lungcanc
Member Stories: Janet Freeman-Daily
lungcanc
IASLC 2020 World Conference on Lung Cancer Postponed
lungcanc
IASLC’s Guide to COVID-19 and Lung Cancer
lungcanc
1
...
8
9
10
...
53
Page 9 of 53
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
